Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ARC19499

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND In recent years, a number of tissue factor pathway inhibitor (TFPI) antagonists have been developed to serve as… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
BACKGROUND Tissue factor pathway inhibitor (TFPI) is the major inhibitor of tissue factor-initiated coagulation, making it an… Expand
Is this relevant?
2012
2012
INTRODUCTION In hemophilia, thrombin generation is significantly suppressed due to decreased factor (F)X activation. Clinical… Expand
Is this relevant?
2012
2012
INTRODUCTION Promoting thrombin generation by inhibiting tissue factor pathway inhibitor (TFPI) is a potentially viable… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Hemophilia A and B are caused by deficiencies in coagulation factor VIII (FVIII) and factor IX, respectively, resulting in… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
2011
2011
BACKGROUND Tissue factor pathway inhibitor (TFPI) is a major regulator of clotting initiation and a promising target for pro- and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Hemophilia A and B are caused by deficiencies in coagulation factor VIII (FVIII) and factor IX, respectively, resulting in… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
2010
2010
Background Hemophilia A and B are disorders resulting from a deficiency in factor VIII (FVIII), and factor IX (FIX), respectively… Expand
Is this relevant?
2010
2010
Abstract 1134 Hemophilia is a bleeding disorder that results from deficiencies in coagulation factor VIII (FVIII; hemophilia A… Expand
Is this relevant?